Global Oncology Based Preclinical CRO Market Research Report 2024(Status and Outlook)
Report Overview:
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The Global Oncology Based Preclinical CRO Market Size was estimated at USD 432.40 million in 2023 and is projected to reach USD 871.93 million by 2029, exhibiting a CAGR of 12.40% during the forecast period.
This report provides a deep insight into the global Oncology Based Preclinical CRO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Based Preclinical CRO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Based Preclinical CRO market in any manner.
Global Oncology Based Preclinical CRO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Market Segmentation (by Type)
Blood Cancer
Solid Tumors
Others
Market Segmentation (by Application)
In Vitro
In Vivo
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Based Preclinical CRO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Preclinical research refers to before testing a drug in people, researchers must find out whether it has the potential to cause serious harm, also called toxicity. A Preclinical CRO, or preclinical contract research organization, provides the experience, knowledge, and skill required to take a pharmaceutical product or medical device from the drawing board to distribution. This journey entails a plethora of activities that involve scientists, medical personnel, administrators, governmental and industry liaisons, marketing experts, and a host of other technical and creative individuals. Rarely is this unique combination of credentials and craft already present within a sponsoring organization. The CRO industry emerged to fill this much-needed role, to provide the expertise required to bring a pharmaceutical product or medical device into the marketplace as quickly and smoothly as possible.
The Global Oncology Based Preclinical CRO Market Size was estimated at USD 432.40 million in 2023 and is projected to reach USD 871.93 million by 2029, exhibiting a CAGR of 12.40% during the forecast period.
This report provides a deep insight into the global Oncology Based Preclinical CRO market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Oncology Based Preclinical CRO Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Oncology Based Preclinical CRO market in any manner.
Global Oncology Based Preclinical CRO Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Crown Bioscience
Charles River
ICON
Eurofins Scientific
Taconic Biosciences
Covance
EVOTEC
The Jackson Laboratory
MI Bioresearch
Champion Oncology
Wuxi AppTec.
Xentech
Living Tumor Laboratory
Market Segmentation (by Type)
Blood Cancer
Solid Tumors
Others
Market Segmentation (by Application)
In Vitro
In Vivo
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Oncology Based Preclinical CRO Market
- Overview of the regional outlook of the Oncology Based Preclinical CRO Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Oncology Based Preclinical CRO Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Oncology Based Preclinical CRO
1.2 Key Market Segments
1.2.1 Oncology Based Preclinical CRO Segment by Type
1.2.2 Oncology Based Preclinical CRO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY BASED PRECLINICAL CRO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Based Preclinical CRO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Based Preclinical CRO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY BASED PRECLINICAL CRO MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncology Based Preclinical CRO Sales by Manufacturers (2019-2024)
3.2 Global Oncology Based Preclinical CRO Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Based Preclinical CRO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Based Preclinical CRO Sales Sites, Area Served, Product Type
3.6 Oncology Based Preclinical CRO Market Competitive Situation and Trends
3.6.1 Oncology Based Preclinical CRO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Based Preclinical CRO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY BASED PRECLINICAL CRO INDUSTRY CHAIN ANALYSIS
4.1 Oncology Based Preclinical CRO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY BASED PRECLINICAL CRO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLOGY BASED PRECLINICAL CRO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Based Preclinical CRO Sales Market Share by Type (2019-2024)
6.3 Global Oncology Based Preclinical CRO Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Based Preclinical CRO Price by Type (2019-2024)
7 ONCOLOGY BASED PRECLINICAL CRO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Based Preclinical CRO Market Sales by Application (2019-2024)
7.3 Global Oncology Based Preclinical CRO Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Based Preclinical CRO Sales Growth Rate by Application (2019-2024)
8 ONCOLOGY BASED PRECLINICAL CRO MARKET SEGMENTATION BY REGION
8.1 Global Oncology Based Preclinical CRO Sales by Region
8.1.1 Global Oncology Based Preclinical CRO Sales by Region
8.1.2 Global Oncology Based Preclinical CRO Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Based Preclinical CRO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Based Preclinical CRO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Based Preclinical CRO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Based Preclinical CRO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Based Preclinical CRO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Crown Bioscience
9.1.1 Crown Bioscience Oncology Based Preclinical CRO Basic Information
9.1.2 Crown Bioscience Oncology Based Preclinical CRO Product Overview
9.1.3 Crown Bioscience Oncology Based Preclinical CRO Product Market Performance
9.1.4 Crown Bioscience Business Overview
9.1.5 Crown Bioscience Oncology Based Preclinical CRO SWOT Analysis
9.1.6 Crown Bioscience Recent Developments
9.2 Charles River
9.2.1 Charles River Oncology Based Preclinical CRO Basic Information
9.2.2 Charles River Oncology Based Preclinical CRO Product Overview
9.2.3 Charles River Oncology Based Preclinical CRO Product Market Performance
9.2.4 Charles River Business Overview
9.2.5 Charles River Oncology Based Preclinical CRO SWOT Analysis
9.2.6 Charles River Recent Developments
9.3 ICON
9.3.1 ICON Oncology Based Preclinical CRO Basic Information
9.3.2 ICON Oncology Based Preclinical CRO Product Overview
9.3.3 ICON Oncology Based Preclinical CRO Product Market Performance
9.3.4 ICON Oncology Based Preclinical CRO SWOT Analysis
9.3.5 ICON Business Overview
9.3.6 ICON Recent Developments
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Oncology Based Preclinical CRO Basic Information
9.4.2 Eurofins Scientific Oncology Based Preclinical CRO Product Overview
9.4.3 Eurofins Scientific Oncology Based Preclinical CRO Product Market Performance
9.4.4 Eurofins Scientific Business Overview
9.4.5 Eurofins Scientific Recent Developments
9.5 Taconic Biosciences
9.5.1 Taconic Biosciences Oncology Based Preclinical CRO Basic Information
9.5.2 Taconic Biosciences Oncology Based Preclinical CRO Product Overview
9.5.3 Taconic Biosciences Oncology Based Preclinical CRO Product Market Performance
9.5.4 Taconic Biosciences Business Overview
9.5.5 Taconic Biosciences Recent Developments
9.6 Covance
9.6.1 Covance Oncology Based Preclinical CRO Basic Information
9.6.2 Covance Oncology Based Preclinical CRO Product Overview
9.6.3 Covance Oncology Based Preclinical CRO Product Market Performance
9.6.4 Covance Business Overview
9.6.5 Covance Recent Developments
9.7 EVOTEC
9.7.1 EVOTEC Oncology Based Preclinical CRO Basic Information
9.7.2 EVOTEC Oncology Based Preclinical CRO Product Overview
9.7.3 EVOTEC Oncology Based Preclinical CRO Product Market Performance
9.7.4 EVOTEC Business Overview
9.7.5 EVOTEC Recent Developments
9.8 The Jackson Laboratory
9.8.1 The Jackson Laboratory Oncology Based Preclinical CRO Basic Information
9.8.2 The Jackson Laboratory Oncology Based Preclinical CRO Product Overview
9.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Product Market Performance
9.8.4 The Jackson Laboratory Business Overview
9.8.5 The Jackson Laboratory Recent Developments
9.9 MI Bioresearch
9.9.1 MI Bioresearch Oncology Based Preclinical CRO Basic Information
9.9.2 MI Bioresearch Oncology Based Preclinical CRO Product Overview
9.9.3 MI Bioresearch Oncology Based Preclinical CRO Product Market Performance
9.9.4 MI Bioresearch Business Overview
9.9.5 MI Bioresearch Recent Developments
9.10 Champion Oncology
9.10.1 Champion Oncology Oncology Based Preclinical CRO Basic Information
9.10.2 Champion Oncology Oncology Based Preclinical CRO Product Overview
9.10.3 Champion Oncology Oncology Based Preclinical CRO Product Market Performance
9.10.4 Champion Oncology Business Overview
9.10.5 Champion Oncology Recent Developments
9.11 Wuxi AppTec.
9.11.1 Wuxi AppTec. Oncology Based Preclinical CRO Basic Information
9.11.2 Wuxi AppTec. Oncology Based Preclinical CRO Product Overview
9.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Product Market Performance
9.11.4 Wuxi AppTec. Business Overview
9.11.5 Wuxi AppTec. Recent Developments
9.12 Xentech
9.12.1 Xentech Oncology Based Preclinical CRO Basic Information
9.12.2 Xentech Oncology Based Preclinical CRO Product Overview
9.12.3 Xentech Oncology Based Preclinical CRO Product Market Performance
9.12.4 Xentech Business Overview
9.12.5 Xentech Recent Developments
9.13 Living Tumor Laboratory
9.13.1 Living Tumor Laboratory Oncology Based Preclinical CRO Basic Information
9.13.2 Living Tumor Laboratory Oncology Based Preclinical CRO Product Overview
9.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Product Market Performance
9.13.4 Living Tumor Laboratory Business Overview
9.13.5 Living Tumor Laboratory Recent Developments
10 ONCOLOGY BASED PRECLINICAL CRO MARKET FORECAST BY REGION
10.1 Global Oncology Based Preclinical CRO Market Size Forecast
10.2 Global Oncology Based Preclinical CRO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Based Preclinical CRO Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Based Preclinical CRO Market Size Forecast by Region
10.2.4 South America Oncology Based Preclinical CRO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Based Preclinical CRO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oncology Based Preclinical CRO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Based Preclinical CRO by Type (2025-2030)
11.1.2 Global Oncology Based Preclinical CRO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Based Preclinical CRO by Type (2025-2030)
11.2 Global Oncology Based Preclinical CRO Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Based Preclinical CRO Sales (K Units) Forecast by Application
11.2.2 Global Oncology Based Preclinical CRO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Oncology Based Preclinical CRO
1.2 Key Market Segments
1.2.1 Oncology Based Preclinical CRO Segment by Type
1.2.2 Oncology Based Preclinical CRO Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ONCOLOGY BASED PRECLINICAL CRO MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Oncology Based Preclinical CRO Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Oncology Based Preclinical CRO Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ONCOLOGY BASED PRECLINICAL CRO MARKET COMPETITIVE LANDSCAPE
3.1 Global Oncology Based Preclinical CRO Sales by Manufacturers (2019-2024)
3.2 Global Oncology Based Preclinical CRO Revenue Market Share by Manufacturers (2019-2024)
3.3 Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Oncology Based Preclinical CRO Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Oncology Based Preclinical CRO Sales Sites, Area Served, Product Type
3.6 Oncology Based Preclinical CRO Market Competitive Situation and Trends
3.6.1 Oncology Based Preclinical CRO Market Concentration Rate
3.6.2 Global 5 and 10 Largest Oncology Based Preclinical CRO Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ONCOLOGY BASED PRECLINICAL CRO INDUSTRY CHAIN ANALYSIS
4.1 Oncology Based Preclinical CRO Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ONCOLOGY BASED PRECLINICAL CRO MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 ONCOLOGY BASED PRECLINICAL CRO MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Oncology Based Preclinical CRO Sales Market Share by Type (2019-2024)
6.3 Global Oncology Based Preclinical CRO Market Size Market Share by Type (2019-2024)
6.4 Global Oncology Based Preclinical CRO Price by Type (2019-2024)
7 ONCOLOGY BASED PRECLINICAL CRO MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Oncology Based Preclinical CRO Market Sales by Application (2019-2024)
7.3 Global Oncology Based Preclinical CRO Market Size (M USD) by Application (2019-2024)
7.4 Global Oncology Based Preclinical CRO Sales Growth Rate by Application (2019-2024)
8 ONCOLOGY BASED PRECLINICAL CRO MARKET SEGMENTATION BY REGION
8.1 Global Oncology Based Preclinical CRO Sales by Region
8.1.1 Global Oncology Based Preclinical CRO Sales by Region
8.1.2 Global Oncology Based Preclinical CRO Sales Market Share by Region
8.2 North America
8.2.1 North America Oncology Based Preclinical CRO Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Oncology Based Preclinical CRO Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Oncology Based Preclinical CRO Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Oncology Based Preclinical CRO Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Oncology Based Preclinical CRO Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Crown Bioscience
9.1.1 Crown Bioscience Oncology Based Preclinical CRO Basic Information
9.1.2 Crown Bioscience Oncology Based Preclinical CRO Product Overview
9.1.3 Crown Bioscience Oncology Based Preclinical CRO Product Market Performance
9.1.4 Crown Bioscience Business Overview
9.1.5 Crown Bioscience Oncology Based Preclinical CRO SWOT Analysis
9.1.6 Crown Bioscience Recent Developments
9.2 Charles River
9.2.1 Charles River Oncology Based Preclinical CRO Basic Information
9.2.2 Charles River Oncology Based Preclinical CRO Product Overview
9.2.3 Charles River Oncology Based Preclinical CRO Product Market Performance
9.2.4 Charles River Business Overview
9.2.5 Charles River Oncology Based Preclinical CRO SWOT Analysis
9.2.6 Charles River Recent Developments
9.3 ICON
9.3.1 ICON Oncology Based Preclinical CRO Basic Information
9.3.2 ICON Oncology Based Preclinical CRO Product Overview
9.3.3 ICON Oncology Based Preclinical CRO Product Market Performance
9.3.4 ICON Oncology Based Preclinical CRO SWOT Analysis
9.3.5 ICON Business Overview
9.3.6 ICON Recent Developments
9.4 Eurofins Scientific
9.4.1 Eurofins Scientific Oncology Based Preclinical CRO Basic Information
9.4.2 Eurofins Scientific Oncology Based Preclinical CRO Product Overview
9.4.3 Eurofins Scientific Oncology Based Preclinical CRO Product Market Performance
9.4.4 Eurofins Scientific Business Overview
9.4.5 Eurofins Scientific Recent Developments
9.5 Taconic Biosciences
9.5.1 Taconic Biosciences Oncology Based Preclinical CRO Basic Information
9.5.2 Taconic Biosciences Oncology Based Preclinical CRO Product Overview
9.5.3 Taconic Biosciences Oncology Based Preclinical CRO Product Market Performance
9.5.4 Taconic Biosciences Business Overview
9.5.5 Taconic Biosciences Recent Developments
9.6 Covance
9.6.1 Covance Oncology Based Preclinical CRO Basic Information
9.6.2 Covance Oncology Based Preclinical CRO Product Overview
9.6.3 Covance Oncology Based Preclinical CRO Product Market Performance
9.6.4 Covance Business Overview
9.6.5 Covance Recent Developments
9.7 EVOTEC
9.7.1 EVOTEC Oncology Based Preclinical CRO Basic Information
9.7.2 EVOTEC Oncology Based Preclinical CRO Product Overview
9.7.3 EVOTEC Oncology Based Preclinical CRO Product Market Performance
9.7.4 EVOTEC Business Overview
9.7.5 EVOTEC Recent Developments
9.8 The Jackson Laboratory
9.8.1 The Jackson Laboratory Oncology Based Preclinical CRO Basic Information
9.8.2 The Jackson Laboratory Oncology Based Preclinical CRO Product Overview
9.8.3 The Jackson Laboratory Oncology Based Preclinical CRO Product Market Performance
9.8.4 The Jackson Laboratory Business Overview
9.8.5 The Jackson Laboratory Recent Developments
9.9 MI Bioresearch
9.9.1 MI Bioresearch Oncology Based Preclinical CRO Basic Information
9.9.2 MI Bioresearch Oncology Based Preclinical CRO Product Overview
9.9.3 MI Bioresearch Oncology Based Preclinical CRO Product Market Performance
9.9.4 MI Bioresearch Business Overview
9.9.5 MI Bioresearch Recent Developments
9.10 Champion Oncology
9.10.1 Champion Oncology Oncology Based Preclinical CRO Basic Information
9.10.2 Champion Oncology Oncology Based Preclinical CRO Product Overview
9.10.3 Champion Oncology Oncology Based Preclinical CRO Product Market Performance
9.10.4 Champion Oncology Business Overview
9.10.5 Champion Oncology Recent Developments
9.11 Wuxi AppTec.
9.11.1 Wuxi AppTec. Oncology Based Preclinical CRO Basic Information
9.11.2 Wuxi AppTec. Oncology Based Preclinical CRO Product Overview
9.11.3 Wuxi AppTec. Oncology Based Preclinical CRO Product Market Performance
9.11.4 Wuxi AppTec. Business Overview
9.11.5 Wuxi AppTec. Recent Developments
9.12 Xentech
9.12.1 Xentech Oncology Based Preclinical CRO Basic Information
9.12.2 Xentech Oncology Based Preclinical CRO Product Overview
9.12.3 Xentech Oncology Based Preclinical CRO Product Market Performance
9.12.4 Xentech Business Overview
9.12.5 Xentech Recent Developments
9.13 Living Tumor Laboratory
9.13.1 Living Tumor Laboratory Oncology Based Preclinical CRO Basic Information
9.13.2 Living Tumor Laboratory Oncology Based Preclinical CRO Product Overview
9.13.3 Living Tumor Laboratory Oncology Based Preclinical CRO Product Market Performance
9.13.4 Living Tumor Laboratory Business Overview
9.13.5 Living Tumor Laboratory Recent Developments
10 ONCOLOGY BASED PRECLINICAL CRO MARKET FORECAST BY REGION
10.1 Global Oncology Based Preclinical CRO Market Size Forecast
10.2 Global Oncology Based Preclinical CRO Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Oncology Based Preclinical CRO Market Size Forecast by Country
10.2.3 Asia Pacific Oncology Based Preclinical CRO Market Size Forecast by Region
10.2.4 South America Oncology Based Preclinical CRO Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Oncology Based Preclinical CRO by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Oncology Based Preclinical CRO Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Oncology Based Preclinical CRO by Type (2025-2030)
11.1.2 Global Oncology Based Preclinical CRO Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Oncology Based Preclinical CRO by Type (2025-2030)
11.2 Global Oncology Based Preclinical CRO Market Forecast by Application (2025-2030)
11.2.1 Global Oncology Based Preclinical CRO Sales (K Units) Forecast by Application
11.2.2 Global Oncology Based Preclinical CRO Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Based Preclinical CRO Market Size Comparison by Region (M USD)
Table 5. Global Oncology Based Preclinical CRO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Oncology Based Preclinical CRO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncology Based Preclinical CRO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncology Based Preclinical CRO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2022)
Table 10. Global Market Oncology Based Preclinical CRO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncology Based Preclinical CRO Sales Sites and Area Served
Table 12. Manufacturers Oncology Based Preclinical CRO Product Type
Table 13. Global Oncology Based Preclinical CRO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncology Based Preclinical CRO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Based Preclinical CRO Market Challenges
Table 22. Global Oncology Based Preclinical CRO Sales by Type (K Units)
Table 23. Global Oncology Based Preclinical CRO Market Size by Type (M USD)
Table 24. Global Oncology Based Preclinical CRO Sales (K Units) by Type (2019-2024)
Table 25. Global Oncology Based Preclinical CRO Sales Market Share by Type (2019-2024)
Table 26. Global Oncology Based Preclinical CRO Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncology Based Preclinical CRO Market Size Share by Type (2019-2024)
Table 28. Global Oncology Based Preclinical CRO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Oncology Based Preclinical CRO Sales (K Units) by Application
Table 30. Global Oncology Based Preclinical CRO Market Size by Application
Table 31. Global Oncology Based Preclinical CRO Sales by Application (2019-2024) & (K Units)
Table 32. Global Oncology Based Preclinical CRO Sales Market Share by Application (2019-2024)
Table 33. Global Oncology Based Preclinical CRO Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncology Based Preclinical CRO Market Share by Application (2019-2024)
Table 35. Global Oncology Based Preclinical CRO Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncology Based Preclinical CRO Sales by Region (2019-2024) & (K Units)
Table 37. Global Oncology Based Preclinical CRO Sales Market Share by Region (2019-2024)
Table 38. North America Oncology Based Preclinical CRO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Oncology Based Preclinical CRO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Oncology Based Preclinical CRO Sales by Region (2019-2024) & (K Units)
Table 41. South America Oncology Based Preclinical CRO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Oncology Based Preclinical CRO Sales by Region (2019-2024) & (K Units)
Table 43. Crown Bioscience Oncology Based Preclinical CRO Basic Information
Table 44. Crown Bioscience Oncology Based Preclinical CRO Product Overview
Table 45. Crown Bioscience Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Crown Bioscience Business Overview
Table 47. Crown Bioscience Oncology Based Preclinical CRO SWOT Analysis
Table 48. Crown Bioscience Recent Developments
Table 49. Charles River Oncology Based Preclinical CRO Basic Information
Table 50. Charles River Oncology Based Preclinical CRO Product Overview
Table 51. Charles River Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Charles River Business Overview
Table 53. Charles River Oncology Based Preclinical CRO SWOT Analysis
Table 54. Charles River Recent Developments
Table 55. ICON Oncology Based Preclinical CRO Basic Information
Table 56. ICON Oncology Based Preclinical CRO Product Overview
Table 57. ICON Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ICON Oncology Based Preclinical CRO SWOT Analysis
Table 59. ICON Business Overview
Table 60. ICON Recent Developments
Table 61. Eurofins Scientific Oncology Based Preclinical CRO Basic Information
Table 62. Eurofins Scientific Oncology Based Preclinical CRO Product Overview
Table 63. Eurofins Scientific Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Recent Developments
Table 66. Taconic Biosciences Oncology Based Preclinical CRO Basic Information
Table 67. Taconic Biosciences Oncology Based Preclinical CRO Product Overview
Table 68. Taconic Biosciences Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Taconic Biosciences Business Overview
Table 70. Taconic Biosciences Recent Developments
Table 71. Covance Oncology Based Preclinical CRO Basic Information
Table 72. Covance Oncology Based Preclinical CRO Product Overview
Table 73. Covance Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Covance Business Overview
Table 75. Covance Recent Developments
Table 76. EVOTEC Oncology Based Preclinical CRO Basic Information
Table 77. EVOTEC Oncology Based Preclinical CRO Product Overview
Table 78. EVOTEC Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. EVOTEC Business Overview
Table 80. EVOTEC Recent Developments
Table 81. The Jackson Laboratory Oncology Based Preclinical CRO Basic Information
Table 82. The Jackson Laboratory Oncology Based Preclinical CRO Product Overview
Table 83. The Jackson Laboratory Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. The Jackson Laboratory Business Overview
Table 85. The Jackson Laboratory Recent Developments
Table 86. MI Bioresearch Oncology Based Preclinical CRO Basic Information
Table 87. MI Bioresearch Oncology Based Preclinical CRO Product Overview
Table 88. MI Bioresearch Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. MI Bioresearch Business Overview
Table 90. MI Bioresearch Recent Developments
Table 91. Champion Oncology Oncology Based Preclinical CRO Basic Information
Table 92. Champion Oncology Oncology Based Preclinical CRO Product Overview
Table 93. Champion Oncology Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Champion Oncology Business Overview
Table 95. Champion Oncology Recent Developments
Table 96. Wuxi AppTec. Oncology Based Preclinical CRO Basic Information
Table 97. Wuxi AppTec. Oncology Based Preclinical CRO Product Overview
Table 98. Wuxi AppTec. Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Wuxi AppTec. Business Overview
Table 100. Wuxi AppTec. Recent Developments
Table 101. Xentech Oncology Based Preclinical CRO Basic Information
Table 102. Xentech Oncology Based Preclinical CRO Product Overview
Table 103. Xentech Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Xentech Business Overview
Table 105. Xentech Recent Developments
Table 106. Living Tumor Laboratory Oncology Based Preclinical CRO Basic Information
Table 107. Living Tumor Laboratory Oncology Based Preclinical CRO Product Overview
Table 108. Living Tumor Laboratory Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Living Tumor Laboratory Business Overview
Table 110. Living Tumor Laboratory Recent Developments
Table 111. Global Oncology Based Preclinical CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Oncology Based Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Oncology Based Preclinical CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Oncology Based Preclinical CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Oncology Based Preclinical CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Oncology Based Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Oncology Based Preclinical CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Oncology Based Preclinical CRO Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Oncology Based Preclinical CRO Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Oncology Based Preclinical CRO Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Oncology Based Preclinical CRO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Oncology Based Preclinical CRO Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Oncology Based Preclinical CRO Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Oncology Based Preclinical CRO Market Size Comparison by Region (M USD)
Table 5. Global Oncology Based Preclinical CRO Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Oncology Based Preclinical CRO Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Oncology Based Preclinical CRO Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Oncology Based Preclinical CRO Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oncology Based Preclinical CRO as of 2022)
Table 10. Global Market Oncology Based Preclinical CRO Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Oncology Based Preclinical CRO Sales Sites and Area Served
Table 12. Manufacturers Oncology Based Preclinical CRO Product Type
Table 13. Global Oncology Based Preclinical CRO Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Oncology Based Preclinical CRO
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Oncology Based Preclinical CRO Market Challenges
Table 22. Global Oncology Based Preclinical CRO Sales by Type (K Units)
Table 23. Global Oncology Based Preclinical CRO Market Size by Type (M USD)
Table 24. Global Oncology Based Preclinical CRO Sales (K Units) by Type (2019-2024)
Table 25. Global Oncology Based Preclinical CRO Sales Market Share by Type (2019-2024)
Table 26. Global Oncology Based Preclinical CRO Market Size (M USD) by Type (2019-2024)
Table 27. Global Oncology Based Preclinical CRO Market Size Share by Type (2019-2024)
Table 28. Global Oncology Based Preclinical CRO Price (USD/Unit) by Type (2019-2024)
Table 29. Global Oncology Based Preclinical CRO Sales (K Units) by Application
Table 30. Global Oncology Based Preclinical CRO Market Size by Application
Table 31. Global Oncology Based Preclinical CRO Sales by Application (2019-2024) & (K Units)
Table 32. Global Oncology Based Preclinical CRO Sales Market Share by Application (2019-2024)
Table 33. Global Oncology Based Preclinical CRO Sales by Application (2019-2024) & (M USD)
Table 34. Global Oncology Based Preclinical CRO Market Share by Application (2019-2024)
Table 35. Global Oncology Based Preclinical CRO Sales Growth Rate by Application (2019-2024)
Table 36. Global Oncology Based Preclinical CRO Sales by Region (2019-2024) & (K Units)
Table 37. Global Oncology Based Preclinical CRO Sales Market Share by Region (2019-2024)
Table 38. North America Oncology Based Preclinical CRO Sales by Country (2019-2024) & (K Units)
Table 39. Europe Oncology Based Preclinical CRO Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Oncology Based Preclinical CRO Sales by Region (2019-2024) & (K Units)
Table 41. South America Oncology Based Preclinical CRO Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Oncology Based Preclinical CRO Sales by Region (2019-2024) & (K Units)
Table 43. Crown Bioscience Oncology Based Preclinical CRO Basic Information
Table 44. Crown Bioscience Oncology Based Preclinical CRO Product Overview
Table 45. Crown Bioscience Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Crown Bioscience Business Overview
Table 47. Crown Bioscience Oncology Based Preclinical CRO SWOT Analysis
Table 48. Crown Bioscience Recent Developments
Table 49. Charles River Oncology Based Preclinical CRO Basic Information
Table 50. Charles River Oncology Based Preclinical CRO Product Overview
Table 51. Charles River Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Charles River Business Overview
Table 53. Charles River Oncology Based Preclinical CRO SWOT Analysis
Table 54. Charles River Recent Developments
Table 55. ICON Oncology Based Preclinical CRO Basic Information
Table 56. ICON Oncology Based Preclinical CRO Product Overview
Table 57. ICON Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. ICON Oncology Based Preclinical CRO SWOT Analysis
Table 59. ICON Business Overview
Table 60. ICON Recent Developments
Table 61. Eurofins Scientific Oncology Based Preclinical CRO Basic Information
Table 62. Eurofins Scientific Oncology Based Preclinical CRO Product Overview
Table 63. Eurofins Scientific Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Eurofins Scientific Business Overview
Table 65. Eurofins Scientific Recent Developments
Table 66. Taconic Biosciences Oncology Based Preclinical CRO Basic Information
Table 67. Taconic Biosciences Oncology Based Preclinical CRO Product Overview
Table 68. Taconic Biosciences Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Taconic Biosciences Business Overview
Table 70. Taconic Biosciences Recent Developments
Table 71. Covance Oncology Based Preclinical CRO Basic Information
Table 72. Covance Oncology Based Preclinical CRO Product Overview
Table 73. Covance Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Covance Business Overview
Table 75. Covance Recent Developments
Table 76. EVOTEC Oncology Based Preclinical CRO Basic Information
Table 77. EVOTEC Oncology Based Preclinical CRO Product Overview
Table 78. EVOTEC Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. EVOTEC Business Overview
Table 80. EVOTEC Recent Developments
Table 81. The Jackson Laboratory Oncology Based Preclinical CRO Basic Information
Table 82. The Jackson Laboratory Oncology Based Preclinical CRO Product Overview
Table 83. The Jackson Laboratory Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. The Jackson Laboratory Business Overview
Table 85. The Jackson Laboratory Recent Developments
Table 86. MI Bioresearch Oncology Based Preclinical CRO Basic Information
Table 87. MI Bioresearch Oncology Based Preclinical CRO Product Overview
Table 88. MI Bioresearch Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. MI Bioresearch Business Overview
Table 90. MI Bioresearch Recent Developments
Table 91. Champion Oncology Oncology Based Preclinical CRO Basic Information
Table 92. Champion Oncology Oncology Based Preclinical CRO Product Overview
Table 93. Champion Oncology Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Champion Oncology Business Overview
Table 95. Champion Oncology Recent Developments
Table 96. Wuxi AppTec. Oncology Based Preclinical CRO Basic Information
Table 97. Wuxi AppTec. Oncology Based Preclinical CRO Product Overview
Table 98. Wuxi AppTec. Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Wuxi AppTec. Business Overview
Table 100. Wuxi AppTec. Recent Developments
Table 101. Xentech Oncology Based Preclinical CRO Basic Information
Table 102. Xentech Oncology Based Preclinical CRO Product Overview
Table 103. Xentech Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Xentech Business Overview
Table 105. Xentech Recent Developments
Table 106. Living Tumor Laboratory Oncology Based Preclinical CRO Basic Information
Table 107. Living Tumor Laboratory Oncology Based Preclinical CRO Product Overview
Table 108. Living Tumor Laboratory Oncology Based Preclinical CRO Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Living Tumor Laboratory Business Overview
Table 110. Living Tumor Laboratory Recent Developments
Table 111. Global Oncology Based Preclinical CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 112. Global Oncology Based Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 113. North America Oncology Based Preclinical CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 114. North America Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 115. Europe Oncology Based Preclinical CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 116. Europe Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 117. Asia Pacific Oncology Based Preclinical CRO Sales Forecast by Region (2025-2030) & (K Units)
Table 118. Asia Pacific Oncology Based Preclinical CRO Market Size Forecast by Region (2025-2030) & (M USD)
Table 119. South America Oncology Based Preclinical CRO Sales Forecast by Country (2025-2030) & (K Units)
Table 120. South America Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 121. Middle East and Africa Oncology Based Preclinical CRO Consumption Forecast by Country (2025-2030) & (Units)
Table 122. Middle East and Africa Oncology Based Preclinical CRO Market Size Forecast by Country (2025-2030) & (M USD)
Table 123. Global Oncology Based Preclinical CRO Sales Forecast by Type (2025-2030) & (K Units)
Table 124. Global Oncology Based Preclinical CRO Market Size Forecast by Type (2025-2030) & (M USD)
Table 125. Global Oncology Based Preclinical CRO Price Forecast by Type (2025-2030) & (USD/Unit)
Table 126. Global Oncology Based Preclinical CRO Sales (K Units) Forecast by Application (2025-2030)
Table 127. Global Oncology Based Preclinical CRO Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Oncology Based Preclinical CRO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Based Preclinical CRO Market Size (M USD), 2019-2030
Figure 5. Global Oncology Based Preclinical CRO Market Size (M USD) (2019-2030)
Figure 6. Global Oncology Based Preclinical CRO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Based Preclinical CRO Market Size by Country (M USD)
Figure 11. Oncology Based Preclinical CRO Sales Share by Manufacturers in 2023
Figure 12. Global Oncology Based Preclinical CRO Revenue Share by Manufacturers in 2023
Figure 13. Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncology Based Preclinical CRO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncology Based Preclinical CRO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncology Based Preclinical CRO Market Share by Type
Figure 18. Sales Market Share of Oncology Based Preclinical CRO by Type (2019-2024)
Figure 19. Sales Market Share of Oncology Based Preclinical CRO by Type in 2023
Figure 20. Market Size Share of Oncology Based Preclinical CRO by Type (2019-2024)
Figure 21. Market Size Market Share of Oncology Based Preclinical CRO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncology Based Preclinical CRO Market Share by Application
Figure 24. Global Oncology Based Preclinical CRO Sales Market Share by Application (2019-2024)
Figure 25. Global Oncology Based Preclinical CRO Sales Market Share by Application in 2023
Figure 26. Global Oncology Based Preclinical CRO Market Share by Application (2019-2024)
Figure 27. Global Oncology Based Preclinical CRO Market Share by Application in 2023
Figure 28. Global Oncology Based Preclinical CRO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncology Based Preclinical CRO Sales Market Share by Region (2019-2024)
Figure 30. North America Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Oncology Based Preclinical CRO Sales Market Share by Country in 2023
Figure 32. U.S. Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Oncology Based Preclinical CRO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Oncology Based Preclinical CRO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Oncology Based Preclinical CRO Sales Market Share by Country in 2023
Figure 37. Germany Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Oncology Based Preclinical CRO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Oncology Based Preclinical CRO Sales Market Share by Region in 2023
Figure 44. China Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Oncology Based Preclinical CRO Sales and Growth Rate (K Units)
Figure 50. South America Oncology Based Preclinical CRO Sales Market Share by Country in 2023
Figure 51. Brazil Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Oncology Based Preclinical CRO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Oncology Based Preclinical CRO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Oncology Based Preclinical CRO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Oncology Based Preclinical CRO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oncology Based Preclinical CRO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oncology Based Preclinical CRO Market Share Forecast by Type (2025-2030)
Figure 65. Global Oncology Based Preclinical CRO Sales Forecast by Application (2025-2030)
Figure 66. Global Oncology Based Preclinical CRO Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Oncology Based Preclinical CRO
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Oncology Based Preclinical CRO Market Size (M USD), 2019-2030
Figure 5. Global Oncology Based Preclinical CRO Market Size (M USD) (2019-2030)
Figure 6. Global Oncology Based Preclinical CRO Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Oncology Based Preclinical CRO Market Size by Country (M USD)
Figure 11. Oncology Based Preclinical CRO Sales Share by Manufacturers in 2023
Figure 12. Global Oncology Based Preclinical CRO Revenue Share by Manufacturers in 2023
Figure 13. Oncology Based Preclinical CRO Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Oncology Based Preclinical CRO Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Oncology Based Preclinical CRO Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Oncology Based Preclinical CRO Market Share by Type
Figure 18. Sales Market Share of Oncology Based Preclinical CRO by Type (2019-2024)
Figure 19. Sales Market Share of Oncology Based Preclinical CRO by Type in 2023
Figure 20. Market Size Share of Oncology Based Preclinical CRO by Type (2019-2024)
Figure 21. Market Size Market Share of Oncology Based Preclinical CRO by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Oncology Based Preclinical CRO Market Share by Application
Figure 24. Global Oncology Based Preclinical CRO Sales Market Share by Application (2019-2024)
Figure 25. Global Oncology Based Preclinical CRO Sales Market Share by Application in 2023
Figure 26. Global Oncology Based Preclinical CRO Market Share by Application (2019-2024)
Figure 27. Global Oncology Based Preclinical CRO Market Share by Application in 2023
Figure 28. Global Oncology Based Preclinical CRO Sales Growth Rate by Application (2019-2024)
Figure 29. Global Oncology Based Preclinical CRO Sales Market Share by Region (2019-2024)
Figure 30. North America Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Oncology Based Preclinical CRO Sales Market Share by Country in 2023
Figure 32. U.S. Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Oncology Based Preclinical CRO Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Oncology Based Preclinical CRO Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Oncology Based Preclinical CRO Sales Market Share by Country in 2023
Figure 37. Germany Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Oncology Based Preclinical CRO Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Oncology Based Preclinical CRO Sales Market Share by Region in 2023
Figure 44. China Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Oncology Based Preclinical CRO Sales and Growth Rate (K Units)
Figure 50. South America Oncology Based Preclinical CRO Sales Market Share by Country in 2023
Figure 51. Brazil Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Oncology Based Preclinical CRO Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Oncology Based Preclinical CRO Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Oncology Based Preclinical CRO Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Oncology Based Preclinical CRO Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Oncology Based Preclinical CRO Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Oncology Based Preclinical CRO Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Oncology Based Preclinical CRO Market Share Forecast by Type (2025-2030)
Figure 65. Global Oncology Based Preclinical CRO Sales Forecast by Application (2025-2030)
Figure 66. Global Oncology Based Preclinical CRO Market Share Forecast by Application (2025-2030)
